IP Library Granted Patent US 8,602,271
Granted Patent B2
US 8,602,271 · App. 10/878,783 · Granted Dec 10, 2013

Diaphragm seal for use in a medicinal aerosol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,602,271
App. No.
10/878,783
Granted
Dec 10, 2013
Kind
B2
Abstract

The invention comprises a device for delivering an aerosol comprising a diaphragm comprising a first layer with a compression set of 30% or more and a second layer with a compression set of 20% or less. The invention also comprises a device for delivering an aerosol comprising a diaphragm comprising a first layer comprised of an uncrosslinked thermoplastic elastomer and a second layer comprised of a crosslinked rubber.

Claims (26)

1. A device for delivering an aerosol comprising:

a valve stem;

a diaphragm having walls defining a diaphragm aperture, the diaphragm comprising a first layer in contact with the valve stem with a compression set equal to or greater than 30% and a second layer in contact with the valve stem with a compression set equal to or less than 20%, wherein the compression set is measured according to standard test method ASTM D395-97 under the conditions of 22 hours and 70° C.; and

a casing member having walls defining a formulation chamber and a casing aperture, wherein the valve stem passes through the diaphragm aperture and the casing aperture and is in slidable sealing engagement with the diaphragm, and wherein the first layer of the diaphragm having the compression set equal to or greater than 30% is in sealing engagement with the casing member, the device having contained in the formulation chamber thereof a medicinal aerosol formulation.

2. A device according to claim 1 , wherein the first layer comprises a copolymer comprising ethylene.

3. A device according to claim 2 , wherein the copolymer comprises about 80 to about 95 mole percent ethylene.

4. A device according to claim 3 , wherein the copolymer comprises 1-butene.

5. A device according to claim 1 , wherein the second layer comprises a rubber selected from the group consisting of nitrile, butyl, and EPDM.

6. A device according to claim 1 , wherein the relative thickness of the first layer to the second layer is equal to or less than 1:2.

7. A device according to claim 1 , wherein the medicinal aerosol formulation comprises

1,1,1,2-tetrafluoro ethane, 1,1,1,2,3,3,3-heptafluoropropane, or a mixture thereof, in an amount effective to function as a propellant.

8. A device according to claim 7 , wherein the medicinal aerosol formulation comprises about 1 to about 25% by weight ethanol.

9. A device according to claim 1 , wherein the second layer comprises a crosslinked thermoplastic elastomer.

10. A device according to claim 1 , wherein the amount of medicinal aerosol formulation in the formulation chamber is less than about 900 mg.

11. A device for delivering an aerosol comprising:

a valve stem;

a diaphragm having walls defining a diaphragm aperture, the diaphragm comprising a first layer in contact with the valve stem comprised of an uncrosslinked thermoplastic elastomer and a second layer in contact with the valve stem comprised of a crosslinked rubber, wherein the first layer has a compression set equal to or more than 30%, the compression set being measured according to ASTM D395-97 under the conditions of 22 hours and 70° C.; and

a casing member having walls defining a formulation chamber and a casing aperture, wherein the valve stem passes through the diaphragm aperture and the casing aperture and is in slidable sealing engagement with the diaphragm, and wherein the first layer of the diaphragm having a compression set equal to or greater than 30% is in sealing engagement with the casing member, the device having contained in the formulation chamber thereof a medicinal aerosol formulation.

12. A device according to claim 11 , wherein the first layer comprises a copolymer comprising ethylene.

13. A device according to claim 12 , wherein the copolymer comprises about 80 to about 95 mole percent ethylene.

14. A device according to claim 13 , wherein the copolymer comprises 1-butene.

15. A device according to claim 11 , wherein the second layer comprises a rubber selected from the group consisting of nitrile, butyl, and EPDM.

16. A device according to claim 11 , wherein the relative thickness of the first layer to the second layer is equal to or less than 1:2.

17. A device according to claim 11 , wherein the medicinal aerosol formulation comprises 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, or a mixture thereof, in an amount effective to function as a propellant.

18. A device according to claim 17 , wherein the medicinal aerosol formulation comprises about 1 to about 25% by weight ethanol.

19. A device according to claim 11 , wherein the amount of medicinal aerosol formulation in the formulation chamber is less than about 900 mg.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2004
From: WINKER, THEODORE A.; ALBAND, TODD D.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 015532/0869 →